Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-13

Clinical Trial Update: Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.

View source ↗

Summary

A study analyzing whether metabolic syndrome influences the real-world efficacy of anti-TNF therapy in adults with moderate-to-severe psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-TNF therapy

Snippet

Sponsor: Juan Ruano | Conditions: Psoriasis Vulgaris, Metabolic Syndrome | Status: UNKNOWN